Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Case Rep Neurol Med
Glavni autori: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2016
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://ncbi.nlm.nih.gov/pubmed/27994897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5876798
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items